Chief Technology Officer
Gustavo Olivera is 21st Century Oncology’s Chief Technology Officer. In this role, he oversees all aspects of the physics department and ensures adherence to Medical Physics quality requirements, accreditation requirements and administration, physics vendor management, and applicable state and federal laws. He is also responsible for strategic development of the physics/technology department.
Mr. Olivera obtained his Ph.D in Atomic Physics from the National University of Rosario in 1996. He worked during 1996 and 1997 at the Multidisciplinary Ion Laser Research Center (CIRIL) in Normandy, France where he developed Monte Carlo Codes for water Radiolysis at nanometer level. After a short stage at the International Center for Theoretical Physics in Trieste, Italy, he moved to the University of Wisconsin Madison where he was an Adjunct Associate Professor at the department of Medical Physics until 2009.
He was one of the pioneers in the TomoTherapy(R) field and also one of the original few employees that created the TomoTherapy company and Hi-ART system together with the two founders in 1997. He served as VP of Research from 2006 to 2010 with Accuray, Inc., the manufacturer of TomoTherapy. After a brief period as CTO of Compact Particle Accelerator Corporation (CPAC), he moved to 21st Century Oncology.
Gustavo has authored and contributed to more than one hundred papers in peer-reviewed journals, as well as 7 book chapters. Gustavo has presented more than 100 presentations at international conferences. He also holds more than 20 U.S. and international patents and lead the development on FDA and CE regulated products. He also served as a permanent member of Radiation Therapeutics and Biology Study section of NIH from 2006 to 2010. He is a referee for several professional journals and is a member of AAPM and ESTRO.
Back to Leadership Team